1. Craig Burkhart, Dean Morrell and Lowell Goldsmith. Dermatological Pharmacology. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 1822.
2. Gerald G. Briggs and Roger K. Freeman. P. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 3144-3146.
3. Emer, Jason, M.D. Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on August 2010] [Accessed 30th December 2020] https://clinicaltrials.gov/ct2/show/NCT01177566
4. Thomas Luger, Mark Boguniewicz, Warner Carr, Michael Cork, Mette Deleuran, Lawrence Eichenfield, Philippe Eigenmann, Regina Fölster-Holst, Carlo Gelmetti, Harald Gollnick, Eckard Hamelmann, Adelaide A Hebert, Antonella Muraro, Arnold P Oranje, Amy S Paller, Carle Paul, Luis Puig, Johannes Ring, Elaine Siegfried, Jonathan M Spergel, Georg Stingl, Alain Taieb, Antonio Torrelo, Thomas Werfel and Ulrich Wahn. Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants. NCBI; PMC US National Library of Medicine, National Institute of Health. April 2015. [Accessed 30th December 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657476/
5. Meda Pharma GmBH & Co. KG. and MEDA Manufacturing. Electronic Medicines Compendium (EMC); [Revised on June 2019] [Accessed 30th December 2020] https://www.medicines.org.uk/emc/files/pil.4966.pdf
6. Contract Pharmaceutical Limited. U.S. Food & Drug Administration. [Revised on March 2014] [Accessed 30th December 2020]. https://www.fda.gov/media/73430/download